Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Experimental Cell Research|August 23, 2025
FOXC1 and FOXC2 in Osteogenesis: Emerging roles and therapeutic potential in bone regeneration and remodelingAli Molaei, Emad Molaei, A Wallace Hayes, et al.
Cell Cycle (Georgetown, Tex.)|June 27, 2023
Mas receptor: a potential strategy in the management of ischemic cardiovascular diseasesAli Molaei, Emad Molaei, A Wallace Hayes, et al.
European Journal of Pharmacology|September 28, 2021
Resolvin D1, therapeutic target in acute respiratory distress syndromeEmad Molaei, Ali Molaei, A Wallace Hayes, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 5, 2024
Remdesivir: treatment of COVID-19 in special populationsEmad Molaei, Ali Molaei, A Wallace Hayes, et al.
Food Science & Nutrition|June 17, 2021
Nephroprotective activity of natural products against chemical toxicants: The role of Nrf2/ARE signaling pathwayEmad Molaei, Ali Molaei, Farshad Abedi, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|July 23, 2025
Pre-emptive hydrocortisone therapy in early septic shock: a double-blind, allocation-concealed, pilot randomized controlled trialEhsan Emami, Emad Molaei, Samrand Fattah Ghazi, et al.
Life Sciences|July 30, 2022
LKB1: An emerging therapeutic target for cardiovascular diseasesAli Molaei, Emad Molaei, Hamidreza Sadeghnia, et al.
International Journal of Burns and Trauma|November 29, 2023
Evaluation of silver sulfadiazine 1%-cerium nitrate 2.2% cream efficacy and safety in moderate to severe burn patients: a single-blind randomized clinical trialEmad Molaei, Hedyieh Karbasforooshan, Ali Ahmadabadi, et al.
Pageof 1